Vanguard Global Advisers
IMA

Vanguard Global Advisers’s ImageneBio Inc IMA Stock Holding History

Vanguard Global Advisers’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.55K Hold
602
– – ﹤0.01% 3579
2026
Q1 		$3.01K Buy
+602
New +$3.91K ﹤0.01% 3596

Other funds holding IMA

BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $59.6M AUM 181.61% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Global Advisers's IMA Position: Q2 2026 in Review

Vanguard Global Advisers held its ImageneBio Inc (IMA) position steady in Q2 2026 at 602 shares worth $3.55K. The position accounts for ﹤0.01% of the portfolio, ranked #3579.

Vanguard Global Advisers first reported a position in IMA in Q1 2026 and has held it in 2 quarters since. 31 funds tracked by Wall St. Rank hold IMA as of Q2 2026.

  • Vanguard Global Advisers held 602 shares of ImageneBio Inc worth $3.55K as of Q2 2026.
  • Vanguard Global Advisers left its ImageneBio Inc share count unchanged in Q2 2026.
  • ImageneBio Inc made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #3579 holding.
  • Vanguard Global Advisers first reported a position in ImageneBio Inc in Q1 2026 and has held it in 2 quarters since.
  • 31 funds tracked by Wall St. Rank held ImageneBio Inc as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.